Simple Summary Although colorectal cancer is the third most common type of cancer, its
treatment strategies still have room for improvement, as current techniques carry risks that …

Colon cancer has attracted much attention due to its annually increasing incidence.
Conventional chemotherapeutic drugs are unsatisfactory in clinical application because of …

Colorectal cancer (CRC) is the third most frequently occurring tumor in the human
population. CRCs are usually adenocarcinomatous and originate as a polyp on the inner …

Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and the second
leading cause of cancer death, which accounts for approximately 10% of all new cancer …

Colorectal cancer (CRC) is one of the most common malignancies with a high mortality rate
worldwide. While surgery, chemotherapy, and radiotherapy have shown some effectiveness …

Colorectal cancer (CRC) involving a malignant tumour remains one of the greatest
contributing causes of fatal mortality and has become the third globally ranked malignancy …

Colorectal cancer (CRC) is one of the most common malignancies. The current treatments of
metastatic colorectal cancer (mCRC) are ineffective and the bottleneck problem. It is of …

The development of new effective cancer treatment methods has attracted much attention,
mainly due to the limited efficacy and considerable side effects of currently used cancer …

Nanoparticles are excellent platforms for several biomedical applications, including cancer
treatment. They can incorporate different molecules to produce combinations of …

Surgery followed by adjuvant chemotherapy is a reliable therapy for colon cancer, but is
associated with side effects and risks. Recent advancements in nanobioengineering in the …